Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues ...